These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 25506915)
1. A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patients. Mancuso P; Calleri A; Gregato G; Labanca V; Quarna J; Antoniotti P; Cuppini L; Finocchiaro G; Eoli M; Rosti V; Bertolini F PLoS One; 2014; 9(12):e114713. PubMed ID: 25506915 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecan. Cuppini L; Calleri A; Bruzzone MG; Prodi E; Anghileri E; Pellegatta S; Mancuso P; Porrati P; Di Stefano AL; Ceroni M; Bertolini F; Finocchiaro G; Eoli M PLoS One; 2013; 8(9):e74345. PubMed ID: 24069296 [TBL] [Abstract][Full Text] [Related]
3. Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells. Delorme B; Basire A; Gentile C; Sabatier F; Monsonis F; Desouches C; Blot-Chabaud M; Uzan G; Sampol J; Dignat-George F Thromb Haemost; 2005 Dec; 94(6):1270-9. PubMed ID: 16411405 [TBL] [Abstract][Full Text] [Related]
4. Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas. Smirnov DA; Foulk BW; Doyle GV; Connelly MC; Terstappen LW; O'Hara SM Cancer Res; 2006 Mar; 66(6):2918-22. PubMed ID: 16540638 [TBL] [Abstract][Full Text] [Related]
5. Characterization of CD45-/CD31+/CD105+ circulating cells in the peripheral blood of patients with gynecologic malignancies. Yu HK; Lee HJ; Choi HN; Ahn JH; Choi JY; Song HS; Lee KH; Yoon Y; Yi LS; Kim JS; Kim SJ; Kim TJ Clin Cancer Res; 2013 Oct; 19(19):5340-50. PubMed ID: 23922300 [TBL] [Abstract][Full Text] [Related]
6. Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy. Starlinger P; Brugger P; Reiter C; Schauer D; Sommerfeldt S; Tamandl D; Kuehrer I; Schoppmann SF; Gnant M; Brostjan C Neoplasia; 2011 Oct; 13(10):980-90. PubMed ID: 22028623 [TBL] [Abstract][Full Text] [Related]
7. Reduced expression of CD109 in tumor-associated endothelial cells promotes tumor progression by paracrine interleukin-8 in hepatocellular carcinoma. Ye BG; Sun HC; Zhu XD; Chai ZT; Zhang YY; Ao JY; Cai H; Ma DN; Wang CH; Qin CD; Gao DM; Tang ZY Oncotarget; 2016 May; 7(20):29333-45. PubMed ID: 27121053 [TBL] [Abstract][Full Text] [Related]
8. Differential CD146 expression on circulating versus tissue endothelial cells in rectal cancer patients: implications for circulating endothelial and progenitor cells as biomarkers for antiangiogenic therapy. Duda DG; Cohen KS; di Tomaso E; Au P; Klein RJ; Scadden DT; Willett CG; Jain RK J Clin Oncol; 2006 Mar; 24(9):1449-53. PubMed ID: 16549839 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomustine single agent. A report from the Dutch Neuro-Oncology Group BELOB trial. Beije N; Kraan J; Taal W; van der Holt B; Oosterkamp HM; Walenkamp AM; Beerepoot L; Hanse M; van Linde ME; Otten A; Vernhout RM; de Vos FY; Gratama JW; Sleijfer S; van den Bent MJ Br J Cancer; 2015 Jul; 113(2):226-31. PubMed ID: 26042933 [TBL] [Abstract][Full Text] [Related]
10. Quantification of circulating endothelial cells in peripheral blood of systemic lupus erythematosus patients: a simple and reproducible method of assessing endothelial injury and repair. Elshal M; Abdelaziz A; Abbas A; Mahmoud K; Fathy H; El Mongy S; El-Basyuoni S; Ahmed H; McCoy P Nephrol Dial Transplant; 2009 May; 24(5):1495-9. PubMed ID: 19039027 [TBL] [Abstract][Full Text] [Related]
11. A new approach for rapid and reliable enumeration of circulating endothelial cells in patients. Kraan J; Strijbos MH; Sieuwerts AM; Foekens JA; den Bakker MA; Verhoef C; Sleijfer S; Gratama JW J Thromb Haemost; 2012 May; 10(5):931-9. PubMed ID: 22385979 [TBL] [Abstract][Full Text] [Related]
12. Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer. Goodale D; Phay C; Brown W; Gray-Statchuk L; Furlong P; Lock M; Chin-Yee I; Keeney M; Allan AL Cytometry B Clin Cytom; 2009 Mar; 76(2):107-17. PubMed ID: 18727054 [TBL] [Abstract][Full Text] [Related]
13. Improved diagnosis and prognostication of patients with pleural malignant mesothelioma using biomarkers in pleural effusions and peripheral blood samples - a short report. Beije N; Kraan J; den Bakker MA; Maat APWM; van der Leest C; Cornelissen R; Van NM; Martens JWM; Aerts JGJV; Sleijfer S Cell Oncol (Dordr); 2017 Oct; 40(5):511-519. PubMed ID: 28577209 [TBL] [Abstract][Full Text] [Related]
14. Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Beerepoot LV; Mehra N; Vermaat JS; Zonnenberg BA; Gebbink MF; Voest EE Ann Oncol; 2004 Jan; 15(1):139-45. PubMed ID: 14679134 [TBL] [Abstract][Full Text] [Related]
16. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146. Mostert B; Kraan J; Bolt-de Vries J; van der Spoel P; Sieuwerts AM; Schutte M; Timmermans AM; Foekens R; Martens JW; Gratama JW; Foekens JA; Sleijfer S Breast Cancer Res Treat; 2011 May; 127(1):33-41. PubMed ID: 20379845 [TBL] [Abstract][Full Text] [Related]
17. Real-time PCR of CD146 mRNA in peripheral blood enables the relative quantification of circulating endothelial cells and is an indicator of angiogenesis. Fürstenberger G; von Moos R; Senn HJ; Boneberg EM Br J Cancer; 2005 Oct; 93(7):793-8. PubMed ID: 16160694 [TBL] [Abstract][Full Text] [Related]
18. A Novel Strategy for Detection and Enumeration of Circulating Rare Cell Populations in Metastatic Cancer Patients Using Automated Microfluidic Filtration and Multiplex Immunoassay. Magbanua MJ; Pugia M; Lee JS; Jabon M; Wang V; Gubens M; Marfurt K; Pence J; Sidhu H; Uzgiris A; Rugo HS; Park JW PLoS One; 2015; 10(10):e0141166. PubMed ID: 26496203 [TBL] [Abstract][Full Text] [Related]
19. Isolation of a circulating CD45-, CD34dim cell population and validation of their endothelial phenotype. Tropea MM; Harper BJ; Graninger GM; Phillips TM; Ferreyra G; Mostowski HS; Danner RL; Suffredini AF; Solomon MA Thromb Haemost; 2014 Oct; 112(4):770-80. PubMed ID: 25057108 [TBL] [Abstract][Full Text] [Related]
20. High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies. Taylor M; Rössler J; Geoerger B; Laplanche A; Hartmann O; Vassal G; Farace F Clin Cancer Res; 2009 Jul; 15(14):4561-71. PubMed ID: 19605404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]